Incidence of severe <scp>COVID</scp> ‐19 in patients with chronic lymphocytic leukaemia or indolent B‐cell non‐Hodgkin lymphoma who received vaccination and pre‐exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the <scp>GIMEMA</scp> working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi

Gian Matteo Rigolin, Stefano Soddu, Riccardo Dondolin, Anna Maria Frustaci, Ilaria Scortechini, Francesca Romana Mauro, Francesco Angotzi, Marina Motta, Lydia Scarfò, Andrea Mengarelli, Annamaria Giordano, Sara Martinelli, Caterina Patti, Paolo Sportoletti, Alessandro Sanna, Nilla Maschio, Rossella Riccioni, Clara Virginia Viganò, Agostino Tafuri, Alfonso Piciocchi, Paola Fazi, Stefano Luminari, Andrés J. M. Ferreri, Guido Gini, Paolo Ghia, Antonio Cuneo

Open source

DOI: 10.1111/bjh.70401
Published: 2026-03-10
Container: British Journal of Haematology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70401,
  title = {Incidence of severe
                    <scp>COVID</scp>
                    ‐19 in patients with chronic lymphocytic leukaemia or indolent B‐cell non‐Hodgkin lymphoma who received vaccination and pre‐exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the
                    <scp>GIMEMA</scp>
                    working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi},
  author = {Gian Matteo Rigolin and Stefano Soddu and Riccardo Dondolin and Anna Maria Frustaci and Ilaria Scortechini and Francesca Romana Mauro and Francesco Angotzi and Marina Motta and Lydia Scarfò and Andrea Mengarelli and Annamaria Giordano and Sara Martinelli and Caterina Patti and Paolo Sportoletti and Alessandro Sanna and Nilla Maschio and Rossella Riccioni and Clara Virginia Viganò and Agostino Tafuri and Alfonso Piciocchi and Paola Fazi and Stefano Luminari and Andrés J. M. Ferreri and Guido Gini and Paolo Ghia and Antonio Cuneo},
  year = {2026},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.70401},
  url = {https://doi.org/10.1111/bjh.70401}
}

RIS

TY  - JOUR
TI  - Incidence of severe
                    <scp>COVID</scp>
                    ‐19 in patients with chronic lymphocytic leukaemia or indolent B‐cell non‐Hodgkin lymphoma who received vaccination and pre‐exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the
                    <scp>GIMEMA</scp>
                    working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi
AU  - Gian Matteo Rigolin
AU  - Stefano Soddu
AU  - Riccardo Dondolin
AU  - Anna Maria Frustaci
AU  - Ilaria Scortechini
AU  - Francesca Romana Mauro
AU  - Francesco Angotzi
AU  - Marina Motta
AU  - Lydia Scarfò
AU  - Andrea Mengarelli
AU  - Annamaria Giordano
AU  - Sara Martinelli
AU  - Caterina Patti
AU  - Paolo Sportoletti
AU  - Alessandro Sanna
AU  - Nilla Maschio
AU  - Rossella Riccioni
AU  - Clara Virginia Viganò
AU  - Agostino Tafuri
AU  - Alfonso Piciocchi
AU  - Paola Fazi
AU  - Stefano Luminari
AU  - Andrés J. M. Ferreri
AU  - Guido Gini
AU  - Paolo Ghia
AU  - Antonio Cuneo
PY  - 2026
JO  - British Journal of Haematology
DO  - 10.1111/bjh.70401
UR  - https://doi.org/10.1111/bjh.70401
ER  -

APA

Rigolin, G. M., Soddu, S., Dondolin, R., Frustaci, A. M., Scortechini, I., Mauro, F. R., Angotzi, F., Motta, M., Scarfò, L., Mengarelli, A., Giordano, A., Martinelli, S., Patti, C., Sportoletti, P., Sanna, A., Maschio, N., Riccioni, R., Viganò, C. V., Tafuri, A., Piciocchi, A., Fazi, P., Luminari, S., Ferreri, A. J. M., Gini, G., Ghia, P., & Cuneo, A. (2026). Incidence of severe <scp>COVID</scp> ‐19 in patients with chronic lymphocytic leukaemia or indolent B‐cell non‐Hodgkin lymphoma who received vaccination and pre‐exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the <scp>GIMEMA</scp> working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi. British Journal of Haematology. https://doi.org/10.1111/bjh.70401

Source records

crossref · retrieved 2026-09-27T16:08:48.355Z